THE DEAL, AT A GLANCE
From the announcementConcordare Trials
01What it does“Every day a trial runs late, a patient is waiting,” said Zach Sawaged, CEO and founder of Concordare Trials.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Surface Ventures, Techstars, Innovation Works, GaingelsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedConcordare Trials raised $25M, announced 2026-08-26From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersConcordare Trials' $25M stage-undisclosed financing is a mid-market FinTech capital-flow signal rather than an outlier round, sitting at the 47th percentile of tracked…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Concordare Trials · Financing Record
Explore source-linked visual explanations for Concordare Trials. Unsupported claims are withheld while source review continues.
Record 10979 · Recorded date: 2026-08-26
Explore company records →